Literature DB >> 31207436

The reference liver - ABC and SLC drug transporters in healthy donor and metastatic livers.

Mateusz Kurzawski1, Sylwia Szeląg-Pieniek2, Joanna Łapczuk-Romańska2, Maciej Wrzesiński3, Jerzy Sieńko4, Stefan Oswald5, Marek Droździk2.   

Abstract

BACKGROUND: Analysis of results and conclusions in studies dedicated to pathology of the liver are usually based on comparison of pathological liver specimens and control/reference (considered as healthy) tissues. There are two main sources of the control liver samples used as the reference livers, i.e. deceased organ donor livers and non-tumorous tissue from metastatic livers, which are also applied for drug transporter investigations. However, no information has yet been published on drug transporters in these two major types of reference livers.
METHODS: We explored ABC (P-gp, MRP1, MRP2, MRP3, MRP4, BCRP, BSEP) and SLC (NTCP, MCT1, OCT1, OCT3, OAT2, OATP1B1, OATP1B3, OATP2B1) family transporters expression (qPCR) and protein abundance (LC-MS/MS) in healthy donors (n = 9) and metastatic (n = 13) livers.
RESULTS: The analysis of mRNA content revealed significant differences in ABCB11, ABCC1, ABCG2, SLC10A1, SLC16A1, SLCO1B1 and SLCO2B1 gene expression between livers from organ donors and patients who underwent surgical resection of metastatic tumors. The protein abundance of NTCP was significantly higher, whereas of P-gp significantly lower in non-tumorous tissues from metastatic livers. Greater inter-individual variability in protein abundance of all studied transporters in subjects with metastatic colon cancer was also observed.
CONCLUSIONS: The results suggest that final conclusions in liver pathology studies may depend on the reference liver tissue used, especially in gene expression studies.
Copyright © 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug transporters; Expression; Liver; Protein abundance

Year:  2019        PMID: 31207436     DOI: 10.1016/j.pharep.2019.04.001

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  7 in total

1.  Hepatic Expression of the Na+-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation.

Authors:  Roman Tremmel; Anne T Nies; Barbara A C van Eijck; Niklas Handin; Mathias Haag; Stefan Winter; Florian A Büttner; Charlotte Kölz; Franziska Klein; Pascale Mazzola; Ute Hofmann; Kathrin Klein; Per Hoffmann; Markus M Nöthen; Fabienne Z Gaugaz; Per Artursson; Matthias Schwab; Elke Schaeffeler
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

Review 2.  The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates.

Authors:  Erkka Järvinen; Feng Deng; Wilma Kiander; Alli Sinokki; Heidi Kidron; Noora Sjöstedt
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

3.  The reference liver-CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype.

Authors:  Mateusz Kurzawski; Sylwia Szeląg-Pieniek; Joanna Łapczuk-Romańska; Maciej Wrzesiński; Stefan Oswald; Marek Droździk
Journal:  Pharmacol Rep       Date:  2021-11-06       Impact factor: 3.024

4.  Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects.

Authors:  Areti-Maria Vasilogianni; Zubida M Al-Majdoub; Brahim Achour; Sheila Annie Peters; Amin Rostami-Hodjegan; Jill Barber
Journal:  Br J Clin Pharmacol       Date:  2021-12-03       Impact factor: 3.716

5.  Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis.

Authors:  Areti-Maria Vasilogianni; Zubida M Al-Majdoub; Brahim Achour; Sheila Annie Peters; Jill Barber; Amin Rostami-Hodjegan
Journal:  Clin Pharmacol Ther       Date:  2022-05-21       Impact factor: 6.903

6.  Membrane Transporters in Human Parotid Gland-Targeted Proteomics Approach.

Authors:  Joanna Lapczuk-Romanska; Diana Busch; Ewa Gieruszczak; Agnieszka Drozdzik; Katarzyna Piotrowska; Robert Kowalczyk; Stefan Oswald; Marek Drozdzik
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923

7.  Monocarboxylate Transporter 1 (MCT1) in Liver Pathology.

Authors:  Marek Droździk; Sylwia Szeląg-Pieniek; Justyna Grzegółkowska; Joanna Łapczuk-Romańska; Mariola Post; Pawel Domagała; Janusz Miętkiewski; Stefan Oswald; Mateusz Kurzawski
Journal:  Int J Mol Sci       Date:  2020-02-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.